Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses?

Journal of Medical Virology

Volumn 85, Issue 11, 2013, Pages 1955-1959

  Ozsurekci, Yasemin ^a   Arasli, Mehmet ^b   Oncel, Eda Karadag ^a   Caglayik, Dilek Yagci ^c   Kaya, Ali ^d   Icagasioglu, Fusun Dilara ^d   Engin, Aynur ^d   Korukluoglu, Gulay ^c   Elaldi, Nazif ^d   Ceyhan, Mehmet ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

^c Refik Saydam National Public Health Agency   (Turkey)

^d CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adults; Children; Crimean Congo hemorrhagic fever; Cytokine; Severity of disease

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; PROTEIN P70; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHILDHOOD DISEASE; CRIMEAN CONGO HEMORRHAGIC FEVER; CYTOKINE RESPONSE; DISEASE COURSE; DISEASE SEVERITY; FATALITY; FEMALE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; NAIRO VIRUS; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SEROLOGY; STATISTICAL SIGNIFICANCE;

ADULTS; CHILDREN; CRIMEAN-CONGO HEMORRHAGIC FEVER; CYTOKINE; SEVERITY OF DISEASE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CONGO; CYTOKINES; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; INFANT; MALE; MIDDLE AGED; SERUM; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84883053550     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23697     Document Type: Article

References (34)

1. Andersson I, Lundkvist A, Haller O, Mirazimi A. 2006. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol 78:216-222.
2. Andersson I, Karlberg H, Mousavi-Jazi M, Martinez-Sobrido L, Weber F, Mirazimi A. 2008. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J Med Virol 80:1397-1404.
3. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H. 2005. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: A multicenter study of clinical features and outcome measures. J Med Microbiol 54:385-389.
4. Bente DA, Alimonti JB, Shieh WJ, Camus G, Ströher U, Zaki S, Jones SM. 2010. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol 84:11089-11100.
5. Bowick GC, Airo AM, Bente DA. 2012. Expression of interferon-induced antiviral genes is delayed in STAT1 knockout mouse model of Crimean-Congo hemorrhagic fever. Virol J 9:122.
6. Connolly-Andersen AM, Moll G, Andersson C, Akerström S, Karlberg H, Douagi I, Mirazimi A. 2011. Crimean-Congo hemorrhagic fever virus activates andothelial cells. J Virol 85:7766-7774.
7. Cosgriff TM, Morrill JC, Jennings GB, Hodgson LA, Slayter MV, Gibbs PH, Peters CJ. 1989. The hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys. Rev Infect Dis 11:807-814.
8. Devhare PB, Chatterjee SN, Arankalle VA, Lole KS. 2013. Analysis of antiviral response in human epithelial cells infected with hepatitis e virus. PLoS ONE 8:e63793.
9. Dilber E, Cakir M, Acar A, Orhan F, Yari{dotless}s N, Bahat E, Okten A, Erduran E. 2009. Crimean-Congo hemorrhagic fever among children in north-eastern Turkey. Ann Trop Paediatr 29:23-28.
10. Ergonul O. 2006. Crimean-Congo hemorrhagic fever. Lancet Infect Dis 6:203-214.
11. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. 2006a. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever virus. J Infect Dis 193:941-944.
12. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. 2006b. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: Severity criteria revisited. Clin Microbiol Infect 12:551-554.
13. Ergonul O. 2007. Clinical and pathologic features of Crimean-Congo hemorrhagic fever. In: Ergonul O, Whitehouse CA, editors. Crimean-Congo hemorrhagic fever: A global perspective. 1st edition. Dordrecht, Netherlands: Springer, pp 207-220.
14. Ergonul O. 2012. Crimean-Congo haemorrhagic fever virus: New outbreaks, new discoveries. Curr Opin Virol 2:215-220.
15. Estrada-Pena A, Jameson L, Medlock J, Vatansever Z, Tishkova F. 2012. Unraveling the ecological complexities of tick-associated Crimean-Congo hemorrhagic fever virus transmission: A gap analysis for the western Palearctic. Vector Borne Zoonotic Dis 12:743-752.
16. Gul I, Kaya A, Güven AS, Karapi{dotless}nar H, Küçükdurmaz Z, Yilmaz A, Icagasioglu FD, Tandogan I. 2011. Cardiac findings in children with Crimean-Congo hemorrhagic fever. Med Sci Monit 17:457-460.
17. Haller O, Kochs G, Weber F. 2006. The interferon response circuit: Induction and suppression by pathogenic viruses. Virology 344:119-130.
18. Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldi N, Guner R, Koksal I, Kurt H, Senturk GC. 2012. Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis 12:805-811.
19. Machado AMC. 2007. Multiple testing correction in medical image analysis. J Math Imaging Vis 29:107-117.
20. Morrill JC, Jenning GB, Johnson AJ, Cosgriff TM, Gibbs PH, Peters CJ. 1990. Pathogenesis of Rift Valley fever in rhesus monkeys: Role of interferon response. Arch Virol 110:195-212.
21. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. 2006. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 36:272-276.
22. Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S, Avsic-Zupanc T. 2010. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin Vaccine Immunol 17:1086-1093.
23. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. 2008. Clinical and epidemiologic features of Crimean-Congo haemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J 27:561-563.
24. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. 1989. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 11:794-800.
25. Tezer H, Sayli TR, Metin A, Köker Y, Devrim I, Ergönül O. 2009. Lymphocyte subgroups in children with CCHF: A marker for prognosis. J Infect 59:291-293.
26. Tezer H, Sucakli IA, Sayli TR, Celikel E, Yakut I, Kara A, Tunc B, Ergonul O. 2010. Crimean-Congo hemorrhagic fever in children. J Clin Virol 48:184-186.
27. Tezer H, Ki{dotless}zi{dotless}lgun M, Metin A, Celikel E, Sucakli İA, Kaya A, Kara A, Ceylaner S. 2011. Ki{dotless}ri{dotless}m Kongo Kanamali{dotless} Ateşi ve Sitokinler: Çocuklarda Klinik Bulgularla Bir İlişkisi Var mi? SB-22 J Pediatr Inf 5:267-293.
28. Thomas S, Thomson G, Dowall S, Bruce C, Cook N, Easterbrook L, O'Donoghue L, Summers S, Ajazaj L, Hewson R, Brooks T, Ahmeti S. 2012. Review of Crimean-Congo hemorrhagic fever infection in Kosova in 2008 and 2009: Prolonged viremias and virus detected in urine by PCR. Vector Borne Zoonotic Dis 12:800-804.
29. Tuygun N, Tanir G, Caglayik DY, Uyar Y, Korukluoglu G, Cenesiz F. 2012. Pediatric cases of Crimean-Congo hemorrhagic fever in Turkey. Pediatr Int 54:402-406.
30. Uysal IO, Kaya A, Guven AS, Altuntas EE, Muderris S. 2011. Evaluation of cochlear involvement by transient evoked otoacoustic emission test in children with Crimean-Congo hemorrhagic fever. Int J Pediatr Otorhinolaryngol 75:858-860.
31. Versteeg GA, Garcia-Sastre A. 2010. Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 13:508-516.
32. Weber F, Mirazimi A. 2008. Interferon and cytokine responses to Crimean-Congo hemorrhagic fever virus; an emerging and neglected viral zoonosis. Cytokine Growth Factor Rev 19:395-404.
33. Whitehouse CA. 2004. Crimean-Congo hemorrhagic fever. Antiviral Res 64:145-160.
34. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, Torunoglu MA. 2009. The epidemiology of Crimean-Congo haemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis 13:380-386.